My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ritalin LA 30mg prolonged-release capsules



InfectoPharm Arzneimittel und Consilium GmbHPA1972/002/003

Main Information

Trade NameRitalin LA 30mg prolonged-release capsules
Active SubstancesMethylphenidate hydrochloride
Dosage FormProlonged-release capsule, hard
Licence HolderInfectoPharm Arzneimittel und Consilium GmbH
Licence NumberPA1972/002/003

Group Information

ATC CodeN06BA Centrally acting sympathomimetics
N06BA04 methylphenidate

Status

License statusAuthorised
Licence Issued11/07/2003
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2). This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print